CLINICAL_TRIALS
research
· 2025-11-17
Clinical Trial Update: Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) [Phase 1]
Summary
A phase 1 clinical trial update shows that Candid Therapeutics is conducting a Phase 1 study of Cizutamig for Generalized Myasthenia Gravis, currently recruitin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Candid Therapeutics | Conditions: Generalized Myasthenia Gravis | Phase 1 | Status: RECRUITING